460 related articles for article (PubMed ID: 17008248)
1. Severe Candida albicans panophthalmitis treated with all available and potentially effective antifungal drugs: fluconazole, liposomal amphotericin B, caspofungin, and voriconazole.
Manfredi R; Sabbatani S
Scand J Infect Dis; 2006; 38(10):950-1. PubMed ID: 17008248
[TBL] [Abstract][Full Text] [Related]
2. Voriconazole for candidosis: an important addition?
Graybill JR
Lancet; 2005 Oct 22-28; 366(9495):1413-4. PubMed ID: 16243074
[No Abstract] [Full Text] [Related]
3. Antifungal resistance: the clinical front.
Perfect JR
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 13):15-22. PubMed ID: 15682590
[TBL] [Abstract][Full Text] [Related]
4. Caspofungin for the treatment of azole resistant candidemia in a premature infant.
Smith PB; Steinbach WJ; Cotten CM; Schell WA; Perfect JR; Walsh TJ; Benjamin DK
J Perinatol; 2007 Feb; 27(2):127-9. PubMed ID: 17262048
[TBL] [Abstract][Full Text] [Related]
5. The effects of caspofungin and voriconazole in experimental Candida endophthalmitis.
Kusbeci T; Avci B; Cetinkaya Z; Ozturk F; Yavas G; Ermis SS; Inan UU
Curr Eye Res; 2007 Jan; 32(1):57-64. PubMed ID: 17364736
[TBL] [Abstract][Full Text] [Related]
6. An update on the use of antifungal agents.
Martinez R
J Bras Pneumol; 2006; 32(5):449-60. PubMed ID: 17268750
[TBL] [Abstract][Full Text] [Related]
7. [New developments in antifungal therapy: fluconazole, itraconazole, voriconazole, caspofungin].
van 't Wout JW; Kuijper EJ; Verweij PE; Kullberg BJ
Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1679-84. PubMed ID: 15453120
[TBL] [Abstract][Full Text] [Related]
8. [symbol: see text]Caspofungin and [symbol: see text]voriconazole for fungal infections.
Drug Ther Bull; 2004 Jan; 42(1):5-8. PubMed ID: 14768298
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Almyroudis NG; Sutton DA; Fothergill AW; Rinaldi MG; Kusne S
Antimicrob Agents Chemother; 2007 Jul; 51(7):2587-90. PubMed ID: 17452481
[TBL] [Abstract][Full Text] [Related]
10. Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.
Gahn B; Schub N; Repp R; Gramatzki M
Eur J Med Res; 2007 Aug; 12(8):337-40. PubMed ID: 17933709
[TBL] [Abstract][Full Text] [Related]
11. A case of Aspergillus mediastinitis after heart transplantation successfully treated with liposomal amphotericin B, caspofungin and voriconazole.
Forestier E; Remy V; Lesens O; Martinot M; Hansman Y; Eisenmann B; Christmann D
Eur J Clin Microbiol Infect Dis; 2005 May; 24(5):347-9. PubMed ID: 15889298
[TBL] [Abstract][Full Text] [Related]
12. Caspofungin versus liposomal amphotericin B for empirical therapy.
Danaher PJ
N Engl J Med; 2005 Jan; 352(4):410-4; author reply 410-4. PubMed ID: 15675092
[No Abstract] [Full Text] [Related]
13. Treatment of invasive candidal infections: systematic review and meta-analysis.
Gafter-Gvili A; Vidal L; Goldberg E; Leibovici L; Paul M
Mayo Clin Proc; 2008 Sep; 83(9):1011-21. PubMed ID: 18775201
[TBL] [Abstract][Full Text] [Related]
14. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.
Kullberg BJ; Sobel JD; Ruhnke M; Pappas PG; Viscoli C; Rex JH; Cleary JD; Rubinstein E; Church LW; Brown JM; Schlamm HT; Oborska IT; Hilton F; Hodges MR
Lancet; 2005 Oct 22-28; 366(9495):1435-42. PubMed ID: 16243088
[TBL] [Abstract][Full Text] [Related]
15. Antifungal pharmacotherapy for neonatal candidiasis.
Bliss JM; Wellington M; Gigliotti F
Semin Perinatol; 2003 Oct; 27(5):365-74. PubMed ID: 14626500
[TBL] [Abstract][Full Text] [Related]
16. Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis.
Prabhu RM; Orenstein R
Clin Infect Dis; 2004 Oct; 39(8):1253-4. PubMed ID: 15486856
[No Abstract] [Full Text] [Related]
17. Use of newer antifungal therapies in clinical practice: what do the data tell us?
Perfect JR
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 7):15-23. PubMed ID: 15651178
[TBL] [Abstract][Full Text] [Related]
18. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin.
Breit SM; Hariprasad SM; Mieler WF; Shah GK; Mills MD; Grand MG
Am J Ophthalmol; 2005 Jan; 139(1):135-40. PubMed ID: 15652837
[TBL] [Abstract][Full Text] [Related]
19. Acquired resistance to echinocandins in Candida albicans: case report and review.
Baixench MT; Aoun N; Desnos-Ollivier M; Garcia-Hermoso D; Bretagne S; Ramires S; Piketty C; Dannaoui E
J Antimicrob Chemother; 2007 Jun; 59(6):1076-83. PubMed ID: 17468115
[TBL] [Abstract][Full Text] [Related]
20. Spondylodiscitis caused by Candida krusei: case report and susceptibility patterns.
Pemán J; Jarque I; Bosch M; Cantón E; Salavert M; de Llanos R; Molina A
J Clin Microbiol; 2006 May; 44(5):1912-4. PubMed ID: 16672439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
